Al-Ghazzawi, K.; Neumann, I.; Knetsch, M.; Chen, Y.; Wilde, B.; Bechrakis, N.E.; Eckstein, A.; Oeverhaus, M.
Treatment Outcomes of Patients with Orbital Inflammatory Diseases: Should Steroids Still Be the First Choice? J. Clin. Med. 2024, 13, 3998.
https://doi.org/10.3390/jcm13143998
AMA Style
Al-Ghazzawi K, Neumann I, Knetsch M, Chen Y, Wilde B, Bechrakis NE, Eckstein A, Oeverhaus M.
Treatment Outcomes of Patients with Orbital Inflammatory Diseases: Should Steroids Still Be the First Choice? Journal of Clinical Medicine. 2024; 13(14):3998.
https://doi.org/10.3390/jcm13143998
Chicago/Turabian Style
Al-Ghazzawi, Karim, Inga Neumann, Mareile Knetsch, Ying Chen, Benjamin Wilde, Nikolaos E. Bechrakis, Anja Eckstein, and Michael Oeverhaus.
2024. "Treatment Outcomes of Patients with Orbital Inflammatory Diseases: Should Steroids Still Be the First Choice?" Journal of Clinical Medicine 13, no. 14: 3998.
https://doi.org/10.3390/jcm13143998
APA Style
Al-Ghazzawi, K., Neumann, I., Knetsch, M., Chen, Y., Wilde, B., Bechrakis, N. E., Eckstein, A., & Oeverhaus, M.
(2024). Treatment Outcomes of Patients with Orbital Inflammatory Diseases: Should Steroids Still Be the First Choice? Journal of Clinical Medicine, 13(14), 3998.
https://doi.org/10.3390/jcm13143998